Monoclonal B-cell lymphocytosis

From WikiMD.org
Jump to navigation Jump to search

Monoclonal B-cell lymphocytosis (pronunciation: mɒnəʊˈkləʊn(ə)l biː sɛl lɪmfəʊsaɪˈtoʊsɪs) is a medical condition characterized by the presence of abnormal B cells in the blood. The term is derived from the Greek words monos (meaning single), klonos (meaning twig), lympho (meaning clear fluid), and cytosis (meaning condition of cells).

Definition

Monoclonal B-cell lymphocytosis (MBL) is a condition in which there is an increase in the number of identical B cells in the blood. These cells are produced from a single parent cell, hence the term 'monoclonal'. MBL is often discovered incidentally during routine blood tests and is not associated with any symptoms.

Epidemiology

MBL is more common in older adults and its prevalence increases with age. It is also more common in individuals with a family history of lymphocytic leukemia or other lymphoproliferative disorders.

Clinical Significance

While MBL itself does not cause any symptoms, individuals with MBL have an increased risk of developing chronic lymphocytic leukemia (CLL). However, the majority of individuals with MBL do not develop CLL.

Diagnosis

The diagnosis of MBL is made by identifying an increased number of monoclonal B cells in the blood. This is typically done using flow cytometry, a technique that can identify and measure the number of specific types of cells in a sample of blood.

Treatment

As MBL does not cause any symptoms and most individuals with MBL do not develop CLL, treatment is not typically required. Instead, individuals with MBL are often monitored closely for any signs of progression to CLL.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski